Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential
John A. Hamilton
Expert Review of Clinical Immunology (2015) Vol. 11, Iss. 4, pp. 457-465
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Burkhard Becher, Sònia Tugues, Melanie Greter
Immunity (2016) Vol. 45, Iss. 5, pp. 963-973
Open Access | Times Cited: 484
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
Viktor Umansky, C Blattner, Christoffer Gebhardt, et al.
Vaccines (2016) Vol. 4, Iss. 4, pp. 36-36
Open Access | Times Cited: 365
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Javaid Alam, Ibrahim Jantan, Syed Nasir Abbas Bukhari
Biomedicine & Pharmacotherapy (2017) Vol. 92, pp. 615-633
Closed Access | Times Cited: 260
GM-CSF in inflammation
John A. Hamilton
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 1
Open Access | Times Cited: 230
Immune Cytokines and Their Receptors in Inflammatory Pain
Andrew D. Cook, Anne Deen Christensen, Damini Tewari, et al.
Trends in Immunology (2018) Vol. 39, Iss. 3, pp. 240-255
Closed Access | Times Cited: 221
Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Jianan Zhao, Shicheng Guo, Steven J. Schrodi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 106
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
John A. Hamilton, Andrew D. Cook, Paul P. Tak
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 1, pp. 53-70
Closed Access | Times Cited: 150
Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System
Sabine Spath, Juliana Komuczki, Mario Hermann, et al.
Immunity (2017) Vol. 46, Iss. 2, pp. 245-260
Open Access | Times Cited: 146
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation
Adrian Achuthan, Andrew D. Cook, Ming-Chin Lee, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 9, pp. 3453-3466
Open Access | Times Cited: 142
Granulocyte–macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
Mohit Sachdeva, Philippe Duchâteau, Stéphane Depil, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 14, pp. 5430-5437
Open Access | Times Cited: 140
K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis
Anne Deen Christensen, Claus Haase, Andrew D. Cook, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 127
GM-CSF-Dependent Inflammatory Pathways
John A. Hamilton
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 121
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage
Andrew L. Croxford, Sabine Spath, Burkhard Becher
Trends in Immunology (2015) Vol. 36, Iss. 10, pp. 651-662
Closed Access | Times Cited: 117
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial
Peter C. Taylor, Didier Saurigny, Jiří Vencovský, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Cytokines and Cytokine Receptors
John J. O’Shea, Massimo Gadina, Richard M. Siegel
Elsevier eBooks (2019), pp. 127-155.e1
Closed Access | Times Cited: 78
Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice
Shengjie Li, Aoxiang Zhuge, Kaicen Wang, et al.
Food & Function (2021) Vol. 12, Iss. 20, pp. 10210-10225
Closed Access | Times Cited: 66
CCL17 blockade as a therapy for osteoarthritis pain and disease
Ming-Chin Lee, Reem Saleh, Adrian Achuthan, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 83
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
André A. Teixeira, M. Frank Erasmus, Sara D’Angelo, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages
Amy T. Hsu, Tanya Lupancu, Ming-Chin Lee, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 29, pp. 11415-11423
Open Access | Times Cited: 48
Role of biological agents in treatment of rheumatoid arthritis
Shing T. Law, Peter C. Taylor
Pharmacological Research (2019) Vol. 150, pp. 104497-104497
Open Access | Times Cited: 48
Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
Ke Wang, Meng Lv, Ying‐Jun Chang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Macrophage reprogramming for therapy
Valentina M T Bart, Robert J. Pickering, Philip R. Taylor, et al.
Immunology (2020) Vol. 163, Iss. 2, pp. 128-144
Open Access | Times Cited: 45
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Pattara Rattanawong, Win K. Shen, Hicham El Masry, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 14
Open Access | Times Cited: 41
Group 2 innate lymphoid cells support hematopoietic recovery under stress conditions
Takao Sudo, Yasutaka Motomura, Daisuke Okuzaki, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 40
Targeting GM-CSF in inflammatory and autoimmune disorders
Adrian Achuthan, Ming-Chin Lee, John A. Hamilton
Seminars in Immunology (2021) Vol. 54, pp. 101523-101523
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top